Novo Nordisk and Eli Lilly's weight-loss drugs offer substantial net health benefits and are also cost-effective at current prices – but will still pose an affordability challenge to US healthcare.

Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines. An unusual study presented at the European Society of Cardiology (ESC) congress in ...

The White House has secured another deal with major pharmaceutical companies, this time to offer popular weight loss drugs for less in some cases.

It's safe to say that Xiaomi is the most talked-about new brand on the Indian tech scene today. The Chinese company has not spent any money on advertising and in fact seems pretty laid back about all ...